Ligand validation:6BW5

PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BW5_PGW_A_502	11%	52%	0.274	0.865	0.89	0.97	2	1	2	0	59%	0.5882
6BW5_PGW_B_502	10%	54%	0.298	0.869	0.88	0.89	2	1	0	0	67%	0.6667
6BW5_PGW_D_502	7%	54%	0.355	0.877	0.87	0.91	2	1	2	0	67%	0.6667
6BW5_PGW_C_502	6%	54%	0.338	0.836	0.91	0.87	2	1	5	0	67%	0.6667
6BW6_PGW_B_501	25%	56%	0.205	0.903	0.88	0.8	2	1	0	0	67%	0.6667
6TP6_PGW_A_411	36%	89%	0.177	0.869	0.28	0.36	-	-	4	1	100%	1
6TQ6_PGW_B_404	31%	51%	0.206	0.877	0.94	0.95	2	2	3	0	100%	1
6TQ4_PGW_A_404	23%	47%	0.209	0.834	0.93	1.11	2	4	8	0	100%	1
4K5Y_PGW_B_503	16%	46%	0.263	0.855	0.89	1.18	3	3	1	0	90%	0.902
6TOT_PGW_A_410	12%	49%	0.228	0.754	0.98	1	2	2	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.